In cancer, abnormal epigenetic changes can lead to the activation of oncogenes or the silencing of tumor suppressor genes. Such disruptions can promote uncontrolled cell growth and division, contributing to the development and progression of cancer. For example, hypermethylation of promoter regions of tumor suppressor genes can lead to their silencing, while hypomethylation across the genome can result in genomic instability.
